Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease

Brain. 2017 Jul 1;140(7):2002-2011. doi: 10.1093/brain/awx120.

Abstract

See Kreisl (doi:10.1093/awx151) for a scientific commentary on this article.Subjects with mild cognitive impairment associated with cortical amyloid-β have a greatly increased risk of progressing to Alzheimer's disease. We hypothesized that neuroinflammation occurs early in Alzheimer's disease and would be present in most amyloid-positive mild cognitive impairment cases. 11C-Pittsburgh compound B and 11C-(R)-PK11195 positron emission tomography was used to determine the amyloid load and detect the extent of neuroinflammation (microglial activation) in 42 mild cognitive impairment cases. Twelve age-matched healthy control subjects had 11C-Pittsburgh compound B and 10 healthy control subjects had 11C-(R)-PK11195 positron emission tomography for comparison. Amyloid-positivity was defined as 11C-Pittsburgh compound B target-to-cerebellar ratio above 1.5 within a composite cortical volume of interest. Supervised cluster analysis was used to generate parametric maps of 11C-(R)-PK11195 binding potential. Levels of 11C-(R)-PK11195 binding potential were measured in a selection of cortical volumes of interest and at a voxel level. Twenty-six (62%) of 42 mild cognitive impairment cases showed a raised cortical amyloid load compared to healthy controls. Twenty-two (85%) of the 26 amyloid-positive mild cognitive impairment cases showed clusters of increased cortical microglial activation accompanying the amyloid. There was a positive correlation between levels of amyloid load and 11C-(R)-PK11195 binding potentials at a voxel level within subregions of frontal, parietal and temporal cortices. 11C-(R)-PK11195 positron emission tomography reveals increased inflammation in a majority of amyloid positive mild cognitive impairment cases, its cortical distribution overlapping that of amyloid deposition.

Keywords: Alzheimer's disease; beta-amyloid; microglial activation; mild cognitive impairment; positron emission tomography.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / complications
  • Alzheimer Disease / metabolism*
  • Amyloid / metabolism*
  • Aniline Compounds / metabolism
  • Case-Control Studies
  • Cerebral Cortex / metabolism
  • Cognitive Dysfunction / complications
  • Cognitive Dysfunction / metabolism*
  • Disease Progression
  • Encephalitis / complications
  • Encephalitis / metabolism*
  • Female
  • Humans
  • Isoquinolines / metabolism
  • Male
  • Microglia / immunology
  • Middle Aged
  • Neuropsychological Tests
  • Positron-Emission Tomography
  • Thiazoles / metabolism

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid
  • Aniline Compounds
  • Isoquinolines
  • Thiazoles
  • PK 11195